William Conkling
Chief Executive Officer at RAFAEL HOLDINGS, INC.
Net worth: 934 171 $ as of 2024-04-29
William Conkling active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RAFAEL HOLDINGS, INC. | Chief Executive Officer | 2022-01-31 | - |
| President | 2022-12-31 | - | |
| Corporate Officer/Principal | 2021-03-14 | 2022-01-31 | |
| CYCLO THERAPEUTICS, INC. | Director/Board Member | 2023-05-01 | - |
| Independent Dir/Board Member | 2023-05-01 | - | |
Day Three Labs, Inc.
 Day Three Labs, Inc. Information Technology ServicesTechnology Services Day Three Labs, Inc. is a cannabinoid CPG ingredient manufacturer that specializes in developing and commercializing novel cannabis product solutions. The company is based in Denver, CO, and has research operations in Israel. Day Three Labs taps into over 50 years of scientific research and plant study to reimagine existing cannabis offerings by delivering innovation and ingenuity to the cannabis industry. The company's portfolio includes proprietary pharmaceutical-grade infusion technologies with the objective of handing control of the cannabis experience to the everyday consumer. The company was founded by Rafi Cohen and Joshua David Rubin, and Joshua David Rubin has been the CEO since incorporation. | Director/Board Member | - | - |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Director/Board Member | - | - |
Career history of William Conkling
Former positions of William Conkling
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUNOMEDICS, INC. | Sales & Marketing | 2018-04-30 | 2021-02-28 |
Training of William Conkling
| The Leonard N Stern School of Business | Masters Business Admin |
| Fordham University | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| RAFAEL HOLDINGS, INC. | Finance |
| CYCLO THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Day Three Labs, Inc.
Day Three Labs, Inc. Information Technology ServicesTechnology Services Day Three Labs, Inc. is a cannabinoid CPG ingredient manufacturer that specializes in developing and commercializing novel cannabis product solutions. The company is based in Denver, CO, and has research operations in Israel. Day Three Labs taps into over 50 years of scientific research and plant study to reimagine existing cannabis offerings by delivering innovation and ingenuity to the cannabis industry. The company's portfolio includes proprietary pharmaceutical-grade infusion technologies with the objective of handing control of the cannabis experience to the everyday consumer. The company was founded by Rafi Cohen and Joshua David Rubin, and Joshua David Rubin has been the CEO since incorporation. | Technology Services |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
- Stock Market
- Insiders
- William Conkling
- Experience
